Michael G. Kauffman
2016
In 2016, Michael G. Kauffman earned a total compensation of $1.5M as Chief Executive Officer at Karyopharm Therapeutics, a 66% decrease compared to previous year.
Compensation breakdown
Non-Equity Incentive Plan | $247,200 |
---|---|
Option Awards | $758,523 |
Salary | $515,000 |
Other | $11,260 |
Total | $1,531,983 |
Kauffman received $758.5K in option awards, accounting for 50% of the total pay in 2016.
Kauffman also received $247.2K in non-equity incentive plan, $515K in salary and $11.3K in other compensation.
Rankings
In 2016, Michael G. Kauffman's compensation ranked 6,151st out of 14,075 executives tracked by ExecPay. In other words, Kauffman earned more than 56.3% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 6,151 | 56th |
Manufacturing | 2,253 | 59th |
Chemicals And Allied Products | 741 | 61st |
Drugs | 561 | 64th |
Pharmaceutical Preparations | 440 | 63rd |
Kauffman's colleagues
We found three more compensation records of executives who worked with Michael G. Kauffman at Karyopharm Therapeutics in 2016.
News
Karyopharm Therapeutics CEO Richard Paulson receives $8.4M in 2021
April 8, 2022
Karyopharm Therapeutics CEO Michael Kauffman's 2020 pay jumps 22% to $3.9M
April 7, 2021
Karyopharm Therapeutics CEO Michael Kauffman's 2019 pay jumps 42% to $3.2M
April 9, 2020
Karyopharm Therapeutics Executive Vice President, Chief Commercial Officer Anand Varadan receives $2.3M in 2018
April 19, 2019